Anthony Jarkowski

Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC

Lillian L. Siu, Caroline Even, Éva Remenár et al. · JAMA Oncology · 2018 · 306 citations · Full text

Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy

Dan P. Zandberg, Alain P. Algazi, Antonio Jimeno et al. · European Journal of Cancer · 2018 · 262 citations · Full text

Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC)

Anthony Jarkowski, Ryan Hare, Peter Loud et al. · American Journal of Clinical Oncology · 2014 · 112 citations

Case report of pneumatosis intestinalis secondary to sunitinib treatment for refractory gastrointestinal stromal tumor.

Anthony Jarkowski, Ryan Hare, Valerie Francescutti et al. · PubMed · 2011 · 44 citations

Surgical Oncology, Pneumatosis Intestinalis, Health Sciences +14

Durvalumab for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Preliminary results from a single-arm, phase 2 study

Dan P. Zandberg, Alain P. Algazi, Antonio Jimeno et al. · Annals of Oncology · 2017 · 31 citations · Full text

Medicine, Treatment Resistance, Pathology +9